Table 2

Grading systems for evidence and recommendations in gout CPGs

Name of systemIndicators*No. of guideline in table 1
QOESORQOESOR
OCEBM levels of evidence1a, 1b, 1 c, 2a, 2b, 2 c, 3a, 3b, 4, 5A, B, C, D6, 7, 9, 10, 13
USPSTF ratingsGood, fair, poor/high, moderate, lowA, B, C, D, I2, 4
GRADEA, B, C, D1, 212
ACP grading systemHigh, moderate, lowStrong, weak14
Modified version of the criteria used by CAHTAR SpainModified from SIGN1, 2, 3, 4, 5, 6, 7, 8, 9A, B, C1
Adaptation (based on previous methods used by ACC)A, B, C5
OthersIa, Ib, Ⅱa, Ⅱb, III, IVA, B, C, D, E8
Ia, Ib, Ⅱa, Ⅱb, III, IV0–100 mm visual analogue scale15
1a, 1b, 2a, 2b, 3, 4, 5A, B, C3
  • *The definition of indicators used to indicate QOE and SOR was interpreted in some guidelines (QOE: 10/14, SOR: 10/13). Among these guidelines, five listed the interpretation in a table while others used different methods, such as description in methods part or attaching supplementary materials.

  • ACC, The American College of Cardiology; ACP, American College of Physicians; CAHTAR, The Catalonia Agency for Health Technology Assessment and Research; CPGs, clinical practice guideline; GRADE, Grading of Recommendations Assessment, Development and Evaluation; OCEBM, Oxford Centre for Evidence-Based Medicine; QOE, quality of evidence; SIGN, The Scottish Intercollegiate Guidelines Network; SOR, strength of recommendation; USPSTF, US Preventive Services Task Force.